Biol investor relations
WebApr 12, 2024 · As The Spatial Biology Company ... Sr. Director, Investor Relations Akoya Biosciences, Inc. [email protected]. Akoya Biosciences Media Contact: Christine Quern (617) 650-8497 [email protected]. Enable Medicine Media Contact: Meredith Manuel [email protected]. WebNov 23, 2024 · To schedule a one-on-one meeting or for more information, please contact the Benchmark Company conference coordinators at [email protected] or BIOLASE's investor relations firm, EVC Group, LLC.
Biol investor relations
Did you know?
WebFeb 27, 2024 · Investor Overview FibroGen, Inc. is a leading science-based biopharmaceutical company discovering and developing a pipeline of first-in-class therapeutics. The company applies its pioneering expertise in fibrosis and hypoxia-inducible factor (HIF) biology and clinical development to advance innovative medicines for the … WebAt AGTC we are focused on genetic therapies that can restore visual function in patients with rare inherited conditions. Simple activities such as riding a bike, playing outside, and even the ability to recognize a loved …
WebWhere is BIOLASE, Inc. located? 27042 Towne Centre Drive, Suite 270. Foothill Ranch, CA 92610-2811 USA. WebInvestor Relations. We are a development stage, private biotechnology company working to develop iPSC-derived autologous neuron replacement programs for Parkinson’s disease. Aspen Neuroscience is currently …
WebST. LOUIS, Missouri, MENLO PARK, California– April 12, 2024 – Canopy Biosciences, a Bruker Company, and Enable Medicine, today announced a partnership to provide Enable Medicine’s advanced analysis pipelines for spatial omics data with the Canopy CellScape™ system for quantitative high-plex spatial biology.The partnership will add to the analytic … WebInvestor Relations (IR) combines finance, communication, and marketing to effectively control the flow of information between a public company, its investors, and its stakeholders. Key duties ...
WebFinancial Reports. 中文. 2024 Interim Report. Download (3.22 MB) 2024 Interim Results Announcement. Download (1.88 MB) 2024 Interim Results Presentation.
WebNov 14, 2024 · BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has been invited to participate in the 11th Annual Benchmark Discovery One-on-One Investor Conference taking ... cummings agWebNov 9, 2024 · Earnings announcement* for BIOL: Nov 09, 2024. Biolase, Inc. is estimated to report earnings on 11/09/2024. The upcoming earnings date is derived from an algorithm … cummings africa foundation scholarship formWebDec 31, 2024 · BOSTON , Feb. 01, 2024 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company and a world leader in galectin biology focused on the development of novel treatments for fibrosis and cancer, today announced that management will present at the upcoming SVB Securities. View All Releases. cummings agriWebApr 4, 2024 · 01/30/2024. 8-K. Current report filing. 01/27/2024. 10-Q. Quarterly Report. 1 2 3 Next Last. The SEC information provided is for informational purposes only. Please contact Applied IT’s Investor Relations team at [email protected] for … cummings agri beddingcummings aerospace reviewsWebFind the latest BIOLASE, Inc. (BIOL) stock quote, history, news and other vital information to help you with your stock trading and investing. cummings agency incWebInvestors Investors. Overview; News / Events. Overview; Press Releases; IR Calendar; Email Alerts; Company Info. Overview; Leadership Team; … cummings amendment